The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

$ 28.50

4.6
(464)
In stock
Description

We launched Calibrate with the mission to change the way the world treats weight. In our first year, we have proven that Calibrate works. Our combination of doctor-prescribed, FDA-approved GLP-1…

Inside Calibrate's $20 Million Deal With Madryn to Avoid Bankruptcy

HLTH 2022: Calibrate Launches Enterprise Product to Bring GLP1 Weight Loss Drugs to Payers/Employers

Isabelle Kenyon on LinkedIn: Calibrate Shares Best Real-World Results to Date for Cohort of 11k Members…

Rebecca Torrence on LinkedIn: Inside the struggles at Calibrate, a new kind of weight-loss startup…

Redesign Health Raises $250 Million to Launch Medical Startups - WSJ

The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

Advice for raising capital from 21 top founders who raised over $500M

Isabelle Kenyon - Founder, CEO @ Calibrate - Crunchbase Person Profile

Finding Genius: Isabelle Kenyon, Calibrate

Weight Loss Startup Calibrate Is Changing Hands - MedCity News

Startups Chasing the $100 Billion Market for Weight-Loss Drugs

Exclusive: Telehealth Startup Calibrate Notches A $100 Million Series B From Founders Fund And Tiger Global

Ep439: Isabelle Kenyon Founder & CEO, Calibrate